litlas
Log inCreate account

Christophe Caux

Active 1988–2025

124
Papers
33,184
Citations
84
h-index
120
i10-index

Citations

Citations per year for Christophe Caux1988: 2 citations1989: 4 citations1990: 9 citations1991: 7 citations1992: 18 citations1993: 16 citations1994: 36 citations1995: 79 citations1996: 114 citations1997: 189 citations1998: 183 citations1999: 349 citations2000: 391 citations2001: 494 citations2002: 480 citations2003: 475 citations2004: 466 citations2005: 460 citations2006: 361 citations2007: 406 citations2008: 298 citations2009: 253 citations2010: 247 citations2011: 212 citations2012: 279 citations2013: 255 citations2014: 166 citations2015: 165 citations2016: 141 citations2017: 157 citations2018: 167 citations2019: 601 citations2020: 861 citations2021: 963 citations2022: 767 citations2023: 561 citations2024: 811 citations2025: 424 citations2026: 12 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,849 citing papers, 28.4% of this breakdownChina: 1,395 citing papers, 10.3% of this breakdownGermany: 896 citing papers, 6.6% of this breakdownFrance: 890 citing papers, 6.6% of this breakdownUnited Kingdom: 718 citing papers, 5.3% of this breakdownItaly: 617 citing papers, 4.5% of this breakdownJapan: 524 citing papers, 3.9% of this breakdownNetherlands: 414 citing papers, 3% of this breakdownAustralia: 411 citing papers, 3% of this breakdownCanada: 370 citing papers, 2.7% of this breakdownSwitzerland: 343 citing papers, 2.5% of this breakdownSpain: 262 citing papers, 1.9% of this breakdown
0%28.4%Other 21.3%

Institutions

Fields

  • Immunology and Microbiology51.4%
  • Medicine32.2%
  • Biochemistry, Genetics and Molecular Biology11.5%
  • Engineering1.5%
  • Neuroscience1%
  • Agricultural and Biological Sciences0.7%
  • Other1.7%

Topics

  • Immunotherapy and Immune Responses15%
  • Immune Cell Function and Interaction9.5%
  • T-cell and B-cell Immunology8.7%
  • Cancer Immunotherapy and Biomarkers5.9%
  • Immune Response and Inflammation4%
  • Immune cells in cancer4%
  • Other52.9%

Coauthors

All papers

Open in search
  1. Cold Tumors: A Therapeutic Challenge for Immunotherapy

    Authors: Paola Bonaventura, Tala Shekarian, Vincent Alcazer, Jenny Valladeau‐Guilemond, Sandrine Valsesia‐Wittmann, Sebastián Amigorena, Christophe Caux, Stéphane Depil - Frontiers in Immunology 2019 cited by 1,133

  2. TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway

    Authors: Sébastien Viel, Antoine Marçais, Fernando Guimarães, Róisín M. Loftus, Jessica Rabilloud, Morgan Grau, Sophie Degouve, Sophia Djebali, Amélien Sanlaville, Emily Charrier, Jacques Bienvenu, Julien C. Marie, Christophe Caux, Jacqueline Marvel, Liam Town, Nicholas D. Huntington, Laurent Bartholin, David K. Finlay, Mark J. Smyth, Thierry Walzer - Science Signaling 2016 cited by 640

  3. Immunobiology of Dendritic Cells

    Authors: Jacques Banchereau, Francine Brière, Christophe Caux, Jean Davoust, Serge Lebecque, Yongjun Liu, Bali Pulendran, Karolina Palucka - Annual Review of Immunology 2000 cited by 6,605

  4. Durable and controlled depletion of neutrophils in mice

    Authors: Gaël Boivin, Julien Faget, Pierre‐Benoit Ancey, Aspasia Gkasti, Julie Mussard, Camilla Engblom, Christina Pfirschke, Caroline Contat, Justine Pascual, Jessica Vázquez, Nathalie Bendriss‐Vermare, Christophe Caux, Marie‐Catherine Vozenin, Mikaël J. Pittet, Matthias Gunzer, Etienne Meylan - Nature Communications 2020 cited by 297

  5. Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function

    Authors: Selena Viganó, Dimitrios Alatzoglou, Melita Irving, Christine Ménétrier‐Caux, Christophe Caux, Pedro Romero, George Coukos - Frontiers in Immunology 2019 cited by 427

  6. Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells

    Authors: Béatris Mastelic-Gavillet, Blanca Navarro Rodrigo, Laure Décombaz, Haiping Wang, Giuseppe Ercolano, Rita Ahmed, Leyder Elena Lozano, Angela Ianaro, Laurent Derré, Massimo Valério, Thomas Tawadros, Patrice Jichlinski, Tu Nguyen‐Ngoc, Daniel E. Speiser, Grégory Verdeil, Nicolas Gestermann, Olivier Dormond, Lana E. Kandalaft, George Coukos, Camilla Jandus, Christine Ménétrier‐Caux, Christophe Caux, Ping‐Chih Ho, Pedro Romero, Alexandre Harari, Selena Viganó - Journal for ImmunoTherapy of Cancer 2019 cited by 215

  7. Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?

    Authors: Christine Ménétrier‐Caux, Isabelle Ray‐Coquard, Jean‐Yves Blay, Christophe Caux - Journal for ImmunoTherapy of Cancer 2019 cited by 332

  8. IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer

    Authors: Margaux Hubert, Élisa Gobbini, Coline Couillault, Thien‐Phong Vu Manh, Anne-Claire Doffin, Justine Berthet, Céline Rodriguez, Vincent Ollion, Janice Kielbassa, Christophe Sajous, Isabelle Treilleux, Olivier Trédan, Bertrand Dubois, Marc Dalod, Nathalie Bendriss‐Vermare, Christophe Caux, Jenny Valladeau‐Guilemond - Science Immunology 2020 cited by 142

  9. Recruitment and Expansion of Tregs Cells in the Tumor Environment—How to Target Them?

    Authors: Justine Cinier, Margaux Hubert, Laurie Besson, Anthony Di Roio, Céline Rodriguez, Vincent C. Lombardi, Christophe Caux, Christine Ménétrier‐Caux - Cancers 2021 cited by 107

  10. Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome

    Authors: Michael Gobert, Isabelle Treilleux, Nathalie Bendriss‐Vermare, Thomas Bachelot, Sophie Goddard‐Léon, Vanessa Arfi, Cathy Biota, Anne Claire Doffin, Isabelle Durand, Daniel Olive, Solène Perez, Nicolas Pasqual, Christelle Fauré, Isabelle Ray‐Coquard, Alain Puisieux, Christophe Caux, Jean‐Yves Blay, Christine Ménétrier‐Caux - Cancer Research 2009 cited by 744

  11. Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy

    Authors: Paola Bonaventura, Vincent Alcazer, Virginie Mutez, Laurie Tonon, Juliette Martin, Nicolas Chuvin, Emilie Michel, Rasha E. Boulos, Yann Estornes, Jenny Valladeau‐Guilemond, Alain Viari, Qing Wang, Christophe Caux, Stéphane Depil - Science Advances 2022 cited by 99

  12. Pattern recognition receptors: immune targets to enhance cancer immunotherapy

    Authors: Tala Shekarian, Sandrine Valsesia‐Wittmann, Joshua Brody, Marie-Cécile Michallet, Stéphane Depil, Christophe Caux, Aurélien Marabelle - Annals of Oncology 2017 cited by 178

  13. Impaired IFN-α Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression

    Authors: Vanja Sisirak, Julien Faget, Michael Gobert, Nadège Goutagny, Nelly Vey, Isabelle Treilleux, Sarah Renaudineau, Gaelle Poyet, Sana Intidhar Labidi‐Galy, Sophie Goddard‐Léon, Isabelle Durand, Isabelle Le Mercier, Agathe Bajard, Thomas Bachelot, Alain Puisieux, Isabelle Puisieux, Jean‐Yves Blay, Christine Ménétrier‐Caux, Christophe Caux, Nathalie Bendriss‐Vermare - Cancer Research 2012 cited by 331

  14. The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers

    Authors: Aurélien Voissière, Carlos Gomez‐Roca, Sylvie Chabaud, Céline Rodriguez, Axelle Nkodia, Justine Berthet, Laure Montané, Anne-Sophie Bidaux, Isabelle Treilleux, Lauriane Eberst, C. Terret, Iphigénie Korakis, Gwenaëlle Garin, David Pérol, Jean‐Pierre Delord, Christophe Caux, Bertrand Dubois, Christine Ménétrier‐Caux, Nathalie Bendriss‐Vermare, Philippe A. Cassier - Science Translational Medicine 2024 cited by 54

  15. ZEB1 transcription factor promotes immune escape in melanoma

    Authors: Maud Plaschka, Valentin Benboubker, Maxime Grimont, Justine Berthet, Laurie Tonon, Jonathan Lopez, Myrtille Le-Bouar, B. Balme, G Tondeur, Arnaud de la Fouchardière, Lionel Larue, Alain Puisieux, Yenkel Grinberg‐Bleyer, Nathalie Bendriss‐Vermare, Bertrand Dubois, Christophe Caux, Stéphane Dalle, Julie Caramel - Journal for ImmunoTherapy of Cancer 2022 cited by 106

  16. Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids

    Authors: Nicolas Alcala, Noémie Leblay, Alice‐Agnes Gabriel, Lise Mangiante, David Hervás, Théo Giffon, Anne-Sophie Sertier, Anthony Ferrari, Jules L. Derks, A. Ghantous, Tiffany M. Delhomme, Amélie Chabrier, Cyrille Cuenin, Behnoush Abedi‐Ardekani, Anne Boland, Robert Olaso, Vincent Meyer, Janine Altmüller, Florence Le Calvez‐Kelm, Geoffroy Durand, Catherine Voegele, Sandrine Boyault, Laura Moonen, Nicole Lemaître, P. Lorimier, Anne‐Claire Toffart, Alex Soltermann, Joachim H. Clement, Joerg Saenger, John K. Field, Marie Brevet, Cécile Blanc‐Fournier, Françoise Galateau-Sallé, Nolwenn Le Stang, Prudence A. Russell, Gavin Wright, Gabriella Sozzi, Ugo Pastorino, Stéphanie Lacomme, J Vignaud, Véronique Hofman, Paul Hofman, Odd Terje Brustugun, Marius Lund‐Iversen, Vincent de Montpréville, Lucia Anna Muscarella, Paolo Graziano, Helmut Popper, Jelena Stojšić, Jean‐François Deleuze, Zdenko Herceg, Alain Viari, Peter Nüernberg, Giuseppe Pelosi, Anne‐Marie C. Dingemans, Massimo Milione, Luca Roz, L. Brcic, Marco Volante, Mauro Papotti, Christophe Caux, Juan Sandoval, Héctor Hernández‐Vargas, Élisabeth Brambilla, E.J.M. Speel, Nicolas Girard, Sylvie Lantuéjoul, James McKay, Matthieu Foll, Lynnette Fernandez‐Cuesta - Nature Communications 2019 cited by 214

  17. Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity

    Authors: Lise Mangiante, Nicolas Alcala, Alexandra Sexton‐Oates, Alex Di Genova, Abel González-Pérez, Azhar Khandekar, Erik N. Bergstrom, Jaehee Kim, Xiran Liu, Ricardo Blázquez‐Encinas, Colin Giacobi, Nolwenn Le Stang, Sandrine Boyault, Cyrille Cuenin, Séverine Tabone‐Eglinger, Francesca Damiola, Catherine Voegele, Maude Ardin, Marie‐Cécile Michallet, Lorraine Soudade, Tiffany M. Delhomme, Arnaud Poret, Marie Brevet, Marie‐Christine Copin, Sophie Giusiano, Diane Damotte, Cécile Girard, Véronique Hofman, Paul Hofman, Jérôme Mouroux, Charlotte Cohen, Stéphanie Lacomme, Julien Mazières, Vincent de Montpréville, Corinne Perrin, G. Planchard, Nathalie Rousseau, Isabelle Rouquette, Christine Sagan, Arnaud Scherpereel, F. Thivolet, Jean-Michel Vignaud, Didier Jean, Anabelle Gilg Soit Ilg, Robert Olaso, Vincent Meyer, Anne Boland, Jean‐François Deleuze, Janine Altmüller, Peter Nüernberg, Alejandro Ibáñez‐Costa, Justo P. Castaño, Sylvie Lantuéjoul, Akram Ghantous, Charles Maussion, Pierre Courtiol, Héctor Hernández‐Vargas, Christophe Caux, Nicolas Girard, Núria López-Bigas, Ludmil B. Alexandrov, Françoise Galateau-Sallé, Matthieu Foll, Lynnette Fernandez‐Cuesta - Nature Genetics 2023 cited by 83

  18. Quantitative and Functional Alterations of Plasmacytoid Dendritic Cells Contribute to Immune Tolerance in Ovarian Cancer

    Authors: Sana Intidhar Labidi‐Galy, Vanja Sisirak, Pierre Méeus, Michael Gobert, Isabelle Treilleux, Agathe Bajard, Jean‐Damien Combes, Julien Faget, François Mithieux, Alexandre Cassignol, Olivier Trédan, Isabelle Durand, Christine Ménétrier‐Caux, Christophe Caux, Jean‐Yves Blay, Isabelle Ray‐Coquard, Nathalie Bendriss‐Vermare - Cancer Research 2011 cited by 233

  19. A Milestone Review on How Macrophages Affect Tumor Growth

    Authors: Christophe Caux, Rodrigo Nalio Ramos, George C. Prendergast, Nathalie Bendriss‐Vermare, Christine Ménétrier‐Caux - Cancer Research 2016 cited by 104

  20. Tumor Promotion by Intratumoral Plasmacytoid Dendritic Cells Is Reversed by TLR7 Ligand Treatment

    Authors: Isabelle Le Mercier, Dominique Poujol, Amélien Sanlaville, Vanja Sisirak, Michael Gobert, Isabelle Durand, Bertrand Dubois, Isabelle Treilleux, Jacqueline Marvel, Jaromir Vlach, Jean‐Yves Blay, Nathalie Bendriss‐Vermare, Christophe Caux, Isabelle Puisieux, Nadège Goutagny - Cancer Research 2013 cited by 193

  21. ICOS-Ligand Expression on Plasmacytoid Dendritic Cells Supports Breast Cancer Progression by Promoting the Accumulation of Immunosuppressive CD4+ T Cells

    Authors: Julien Faget, Nathalie Bendriss‐Vermare, Michael Gobert, Isabelle Durand, Daniel Olive, Cathy Biota, Thomas Bachelot, Isabelle Treilleux, Sophie Goddard‐Léon, Emilie Lavergne, Sylvie Chabaud, Jean‐Yves Blay, Christophe Caux, Christine Ménétrier‐Caux - Cancer Research 2012 cited by 210

  22. Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration

    Authors: Mathilde Small, Isabelle Treilleux, Coline Couillault, Daniel Pissaloux, Géraldine Picard, Sandrine Paindavoine, Valéry Attignon, Qing Wang, Véronique Rogemond, S. Lay, Isabelle Ray‐Coquard, Jacobus Pfisterer, Florence Joly, Andreas du Bois, Dimitri Psimaras, Nathalie Bendriss‐Vermare, Christophe Caux, Bertrand Dubois, Jérôme Honnorat, Virginie Desestret - Acta Neuropathologica 2018 cited by 117

  23. Langerin, a Novel C-Type Lectin Specific to Langerhans Cells, Is an Endocytic Receptor that Induces the Formation of Birbeck Granules

    Authors: Jenny Valladeau, Odile Ravel, Colette Dezutter‐Dambuyant, Kevin L. Moore, Monique J. Kleijmeer, Ying Liu, Valérie Duvert-Frances, Claude Vincent, Daniel Schmitt, Jean Davoust, Christophe Caux, Serge Lebecque, Sem Saeland - Immunity 2000 cited by 941

  24. Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients

    Authors: Manuarii Manuel, Olivier Trédan, Thomas Bachelot, Gilles Clapisson, Anaïs Courtier, Gilles Parmentier, Tioka Rabeony, Audrey Grivès, Solène Perez, Jean-François Mouret, David Pérol, Sylvie Chabaud, Isabelle Ray‐Coquard, Sana Intidhar Labidi‐Galy, Pierre‐Etienne Heudel, Jean‐Yves Pierga, Christophe Caux, Jean‐Yves Blay, Nicolas Pasqual, Christine Ménétrier‐Caux - OncoImmunology 2012 cited by 170